Skip to main content

Table 2 Imaging features of DCIS, mIDC, and IDC

From: The role of MRI and clinicopathologic features in predicting the invasive component of biopsy-confirmed ductal carcinoma in situ

  DCIS (n = 112) mIDC (n = 50) IDC (n = 44) P value
Mammography
 Parenchymal density     0.492
  Fatty 20 (17.9) 8 (16.0) 11 (25.0)  
  Dense 92 (82.1) 42 (84.0) 33 (75.0)  
 Calcification     0.025
  Present 65 (58.0) 40 (80.0) 29 (65.9)  
  Absent 47 (42.0) 10 (20.0) 15 (34.1)  
MRI
 BPE     0.145
  Minimal or mild 78 (69.6) 39 (78.0) 37 (84.1)  
  Moderate or marked 34 (30.4) 11 (22.0) 7 (15.9)  
 Multifocality     > 0.999
  Yes 5 (4.5) 2 (4.0) 1 (2.3)  
  No 107 (95.5) 48 (96.0) 43 (97.7)  
 Multicentricity     0.470
  Yes 7 (6.3) 1 (2.0) 1 (2.3)  
  No 105 (93.8) 49 (98.0) 43 (97.7)  
 Type of lesion     0.053
  Non-visualization 11 (9.8) 1 (2.0) 0 (0)  
  Mass 50 (44.6) 18 (36.0) 19 (43.2)  
  NME 51 (45.5) 31 (62.0) 25 (56.8)  
  1. Data values indicate the number of patients (with percentages in parentheses), the mean ± standard deviation, or the median with range.
  2. DCIS ductal carcinoma in situ; mIDC microinvasive ductal carcinoma; IDC invasive ductal carcinoma; BPE background parenchymal enhancement; NME non-mass enhancement